Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Mol Pharm. 2015 May 21;12(6):2180–2188. doi: 10.1021/acs.molpharmaceut.5b00177

Figure 10. The peptide-431 enhances the uptake and apoptotic effect of a pro-apoptotic peptide in LX-2 (A) and HSC-T6 (B) cells.

Figure 10

The peptide-431/KLA fusion peptide, the mixture of peptide-431 and KLA peptide, and KLA peptide were incubated with the cells for 48 h. Cell viability was measured using MTT assay. Results are represented as the mean ± SD (n=3).